167 related articles for article (PubMed ID: 2419034)
1. Natural killer cells.
Kay NE
Crit Rev Clin Lab Sci; 1986; 22(4):343-59. PubMed ID: 2419034
[TBL] [Abstract][Full Text] [Related]
2. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
Katz P; Zaytoun AM; Lee JH; Fauci AS
J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
[No Abstract] [Full Text] [Related]
3. Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.
Virelizier JL; Lipinski M; Tursz T; Griscelli C
Lancet; 1979 Sep; 2(8144):696-7. PubMed ID: 90787
[No Abstract] [Full Text] [Related]
4. [Clinical significance of natural killer cell activity].
Abo T
Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
[No Abstract] [Full Text] [Related]
5. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
Nair MP; Gray RH; Boxer LA; Schwartz SA
Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
[TBL] [Abstract][Full Text] [Related]
6. Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
Haliotis T; Roder J; Klein M; Ortaldo J; Fauci AS; Herberman RB
J Exp Med; 1980 May; 151(5):1039-48. PubMed ID: 6154765
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of lymphocyte populations].
Flad HD
Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
[No Abstract] [Full Text] [Related]
8. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
[TBL] [Abstract][Full Text] [Related]
9. [Interferon and natural killer cells].
Saksela E
Duodecim; 1980; 96(16):1061-4. PubMed ID: 6164530
[No Abstract] [Full Text] [Related]
10. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
[TBL] [Abstract][Full Text] [Related]
11. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
Brahmi Z
Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
[TBL] [Abstract][Full Text] [Related]
12. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
Lotzová E; Savary CA; Gutterman JU; Hersh EM
Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
[No Abstract] [Full Text] [Related]
13. A new immunodeficiency disorder in humans involving NK cells.
Roder JC; Haliotis T; Klein M; Korec S; Jett JR; Ortaldo J; Heberman RB; Katz P; Fauci AS
Nature; 1980 Apr; 284(5756):553-5. PubMed ID: 6445041
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity in a patient with Chédiak-Higashi syndrome submitted to bone marrow transplantation.
Diamond HR; Souza MH; Silva ML; Tabak DG; Ferman S; M-Silva VM; de La Rocque L; Rumjanek VM
Pediatr Hematol Oncol; 1995; 12(4):399-402. PubMed ID: 7577393
[No Abstract] [Full Text] [Related]
15. Further studies of natural killer cell function in Chediak-Higashi patients.
Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
[TBL] [Abstract][Full Text] [Related]
16. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse.
Ito M; Sato A; Tanabe F; Ishida E; Takami Y; Shigeta S
Biochem Biophys Res Commun; 1989 Apr; 160(2):433-40. PubMed ID: 2541700
[TBL] [Abstract][Full Text] [Related]
17. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells in resistance to virus-infected cells.
Rager-Zisman B; Bloom BR
Springer Semin Immunopathol; 1982; 4(4):397-414. PubMed ID: 6183763
[No Abstract] [Full Text] [Related]
19. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
Abo T; Roder JC; Abo W; Cooper MD; Balch CM
J Clin Invest; 1982 Jul; 70(1):193-7. PubMed ID: 7085883
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity in untreated systemic lupus erythematosus.
Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
Ann Rheum Dis; 1982 Aug; 41(4):417-20. PubMed ID: 7114924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
